Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lesaka Technologies (LSAK) Capital Expenditures (2016 - 2025)

Lesaka Technologies (LSAK) has disclosed Capital Expenditures for 17 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 37.92% year-over-year to $3.9 million, compared with a TTM value of $14.8 million through Dec 2025, down 17.41%, and an annual FY2025 reading of $17.2 million, up 35.8% over the prior year.
  • Capital Expenditures was $3.9 million for Q4 2025 at Lesaka Technologies, down from $4.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $6.3 million in Q4 2024 and bottomed at $189000.0 in Q4 2021.
  • Average Capital Expenditures over 5 years is $3.0 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Capital Expenditures tumbled 93.75% in 2021, then skyrocketed 2012.17% in 2022.
  • Year by year, Capital Expenditures stood at $189000.0 in 2021, then surged by 2012.17% to $4.0 million in 2022, then plummeted by 44.94% to $2.2 million in 2023, then skyrocketed by 187.44% to $6.3 million in 2024, then crashed by 37.92% to $3.9 million in 2025.
  • Business Quant data shows Capital Expenditures for LSAK at $3.9 million in Q4 2025, $4.0 million in Q3 2025, and $4.1 million in Q2 2025.